Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2025-12-26 @ 1:52 AM
NCT ID: NCT02062905
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT02062905
Study Brief: OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
OTX-DP Treatment OTX-DP (sustained release dexamethasone, 0.4 mg) OTX-DP treatment None None 1 31 1 31 View
Placebo Plug Delivery Vehicle Placebo Plug with no drug Placebo Plug with no drug None None 0 33 2 33 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
depression None Psychiatric disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
eye discharge None Eye disorders None View